Shenzhen YHLO Biotech Co., Ltd. (SHA:688575)

Market Cap	7.77B -15.0%
Revenue (ttm)	1.90B +0.1%
Net Income	143.32M -50.3%
EPS	0.26 -47.9%
Shares Out	571.39M
PE Ratio	52.15
Forward PE	31.45
Dividend	0.21 (1.54%)
Ex-Dividend Date	Jun 27, 2025

Volume	3,115,023
Average Volume	6,168,134
Open	13.72
Previous Close	13.73
Day's Range	13.60 - 13.79
52-Week Range	13.53 - 18.10
Beta	0.57
RSI	31.26
Earnings Date	Apr 29, 2026

About Shenzhen YHLO Biotech

Shenzhen YHLO Biotech Co., Ltd. researches, develops, produces, sells, and services in vitro diagnostic instruments and reagents in China and internationally. The company offers chemiluminescence immunoassay analyzer, diabetes solution, automated biochemical analyzer, laboratory automation, tenfly phoenix blot analyzer, VISION Pro ESR analyzer, and VISION ESR analyzer. The company was founded in 2008 and is headquartered in Shenzhen, China.

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 2008
• Employees: 1,678
• Stock Exchange: Shanghai Stock Exchange
• Ticker Symbol: 688575

Financial Performance

In 2024, Shenzhen YHLO Biotech's revenue was 2.01 billion, a decrease of -2.02% compared to the previous year's 2.05 billion. Earnings were 301.53 million, a decrease of -15.06%.